CLINICAL_TRIALS
trial_result
· 2025-02-18
Clinical Trial Update: Metformin to Reduce Airway Glucose in COPD Patients [Phase 2]
Summary
Phase 2 trial evaluating metformin to reduce airway glucose in COPD patients has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-02-18